News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AngioChem to Present at the 2013 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference


10/8/2013 7:44:38 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), today announced that an abstract on its most advanced product candidate, ANG1005, has been selected for presentation at the 2013 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference being held October 20-22, 2013 in Boston, MA.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
AngioChem
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES